Katherine R Sabourin1, Ann Reynolds2, Diana Schendel3, Steven Rosenberg4, Lisa A Croen5, Jennifer A Pinto-Martin6, Laura A Schieve7, Craig Newschaffer8, Li-Ching Lee9, Carolyn DiGuiseppi1. 1. Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 2. Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 3. Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH; National Centre for Register-based Research; Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark. 4. Department of Psychiatry, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 5. Kaiser Permanente Division of Research, Oakland, California. 6. University of Pennsylvania School of Nursing and Perelman School of Medicine, Philadelphia, Pennsylvania. 7. National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia. 8. AJ Drexel Autism Institute, Drexel University, Philadelphia, Pennsylvania. 9. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Abstract
Immune system abnormalities have been widely reported among children with autism spectrum disorder (ASD), which may increase the risk of childhood infections. The Study to Explore Early Development (SEED) is a multisite case-control study of children aged 30-69 months, born in 2003-2006. Cases are children previously diagnosed and newly identified with ASD enrolled from education and clinical settings. Children with a previously diagnosed non-ASD developmental condition were included in the developmental delay/disorder (DD) control group. The population (POP) control group included children randomly sampled from birth certificates. Clinical illness from infection during the first 28 days ("neonatal," from medical records) and first three years of life (caregiver report) in cases was compared to DD and POP controls; and between cases with and without regression. Children with ASD had greater odds of neonatal (OR = 1.8; 95%CI: 1.1, 2.9) and early childhood infection (OR = 1.7; 95%CI: 1.5, 1.9) compared to POP children, and greater odds of neonatal infection (OR = 1.5; 95%CI: 1.1, 2.0) compared to DD children. Cases with regression had 1.6 times the odds (95%CI: 1.1, 2.3) of caregiver-reported infection during the first year of life compared to cases without regression, but neonatal infection risk and overall early childhood infection risk did not differ. Our results support the hypothesis that children with ASD are more likely to have infection early in life compared to the general population and to children with other developmental conditions. Future studies should examine the contributions of different causes, timing, frequency, and severity of infection to ASD risk. Autism Research 2019, 12: 136-146.
Immune system abnormalities have been widely reported among children with autism spectrum disorder (ASD), which may increase the risk of childhood infections. The Study to Explore Early Development (SEED) is a multisite case-control study of children aged 30-69 months, born in 2003-2006. Cases are children previously diagnosed and newly identified with ASD enrolled from education and clinical settings. Children with a previously diagnosed non-ASD developmental condition were included in the developmental delay/disorder (DD) control group. The population (POP) control group included children randomly sampled from birth certificates. Clinical illness from infection during the first 28 days ("neonatal," from medical records) and first three years of life (caregiver report) in cases was compared to DD and POP controls; and between cases with and without regression. Children with ASD had greater odds of neonatal (OR = 1.8; 95%CI: 1.1, 2.9) and early childhood infection (OR = 1.7; 95%CI: 1.5, 1.9) compared to POP children, and greater odds of neonatal infection (OR = 1.5; 95%CI: 1.1, 2.0) compared to DD children. Cases with regression had 1.6 times the odds (95%CI: 1.1, 2.3) of caregiver-reported infection during the first year of life compared to cases without regression, but neonatal infection risk and overall early childhood infection risk did not differ. Our results support the hypothesis that children with ASD are more likely to have infection early in life compared to the general population and to children with other developmental conditions. Future studies should examine the contributions of different causes, timing, frequency, and severity of infection to ASD risk. Autism Research 2019, 12: 136-146.
Authors: Ivan Gentile; Emanuela Zappulo; Raffaele Bonavolta; Roberta Maresca; Tullio Messana; Antonio Riccardo Buonomo; Giuseppe Portella; Rosanna Sorrentino; Alessandro Settimi; Antonio Pascotto; Guglielmo Borgia; Carmela Bravaccio Journal: In Vivo Date: 2014 Jul-Aug Impact factor: 2.155
Authors: Lisa D Wiggins; Ann Reynolds; Catherine E Rice; Eric J Moody; Pilar Bernal; Lisa Blaskey; Steven A Rosenberg; Li-Ching Lee; Susan E Levy Journal: J Autism Dev Disord Date: 2015-05
Authors: Ines Serra; Olivia R Manusama; Fabian M P Kaiser; Izi Izumi Floriano; Lucas Wahl; Christian van der Zalm; Hanna IJspeert; P Martin van Hagen; Nico J M van Beveren; Sandra M Arend; Klaus Okkenhaug; Johan J M Pel; Virgil A S H Dalm; Aleksandra Badura Journal: Brain Behav Immun Health Date: 2021-10-19
Authors: Ron Nudel; Wesley K Thompson; Anders D Børglum; David M Hougaard; Preben B Mortensen; Thomas Werge; Merete Nordentoft; Michael E Benros Journal: Transl Psychiatry Date: 2022-08-16 Impact factor: 7.989
Authors: Rosario Trifiletti; Herbert M Lachman; Olivia Manusama; Deyou Zheng; Alberto Spalice; Pietro Chiurazzi; Allan Schornagel; Andreea M Serban; Rogier van Wijck; Janet L Cunningham; Sigrid Swagemakers; Peter J van der Spek Journal: Sci Rep Date: 2022-06-30 Impact factor: 4.996